These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15757473)

  • 1. DNA vaccines for poultry: the jump from theory to practice.
    Haygreen L; Davison F; Kaiser P
    Expert Rev Vaccines; 2005 Feb; 4(1):51-62. PubMed ID: 15757473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
    Davison F; Nair V
    Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In ovo vaccination technology.
    Ricks CA; Avakian A; Bryan T; Gildersleeve R; Haddad E; Ilich R; King S; Murray L; Phelps P; Poston R; Whitfill C; Williams C
    Adv Vet Med; 1999; 41():495-515. PubMed ID: 9890038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV.
    Haygreen EA; Kaiser P; Burgess SC; Davison TF
    Vaccine; 2006 Jun; 24(23):4951-61. PubMed ID: 16621184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
    Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG
    Expert Rev Vaccines; 2005 Feb; 4(1):63-76. PubMed ID: 15757474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken.
    Dilaveris D; Chen C; Kaiser P; Russell PH
    Vaccine; 2007 May; 25(19):3792-9. PubMed ID: 17321645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful control of Marek's disease by vaccination.
    Nair V
    Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of poultry viral vaccines in embryonated eggs.
    Ben-Nathan D
    Adv Biotechnol Processes; 1985; 5():123-47. PubMed ID: 3002406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of immunity following in ovo delivery of avian metapneumovirus vaccines.
    Tarpey I; Huggins MB
    Vet Microbiol; 2007 Sep; 124(1-2):134-9. PubMed ID: 17462834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.
    Avakian AP; Poston RM; Kong FK; Van Kampen KR; Tang DC
    Expert Rev Vaccines; 2007 Jun; 6(3):457-65. PubMed ID: 17542759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In ovo vaccination with the Eimeria tenella EtMIC2 gene induces protective immunity against coccidiosis.
    Ding X; Lillehoj HS; Dalloul RA; Min W; Sato T; Yasuda A; Lillehoj EP
    Vaccine; 2005 May; 23(28):3733-40. PubMed ID: 15882535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens.
    Mahmood MS; Hussain I; Siddique M; Akhtar M; Ali S
    Vaccine; 2007 Nov; 25(44):7629-35. PubMed ID: 17913306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
    Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
    Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field evaluation of the accuracy of vaccine deposition by two different commercially available in ovo injection systems.
    Williams CJ; Hopkins BA
    Poult Sci; 2011 Jan; 90(1):223-6. PubMed ID: 21177463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody.
    Bublot M; Pritchard N; Le Gros FX; Goutebroze S
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S81-4. PubMed ID: 17560594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.